Alirocumab
ATC C10AX14 · 9 markets · 30 records
Alirocumab
Forms
US 4 records · 2 strengths
GB 3 records · 3 strengths
- 300 mg/2 mLinjectionPraluent 75mg/1ml solution for injection pre-filled pens
- 150 mg/1 mLinjectionPraluent 75mg/1ml solution for injection pre-filled pens
- 75 mg/1 mLinjectionPraluent 75mg/1ml solution for injection pre-filled pens
CA 3 records · 3 strengths
ES 3 records · 3 strengths
- 150 mginjectionPRALUENT PRECARGADA
- 75 mginjectionPRALUENT PRECARGADA
- 300 mginjectionPRALUENT PRECARGADA
HK 3 records · 1 strengths
Records without a stated strength · 1 PRALUENT SOLUTION FOR INJECTION IN PRE-FILLED PEN 300MG/2ML、PRALUENT SOLUTION FOR INJECTION IN PREFILLED PEN 150MG/ML
SG 2 records · 2 strengths
- 150 mg/mLinjectionPRALUENT SOLUTION FOR INJECTION IN A PRE-FILLED PEN 150 MG/ML
- 75 mg/mLinjectionPRALUENT SOLUTION FOR INJECTION IN A PRE-FILLED PEN 150 MG/ML
TW 2 records · 2 strengths
- 150 mginjectionPraluent solution for injection 150mg/ml保脂通注射劑150毫克/毫升
- 75 mginjectionPraluent solution for injection 75mg保脂通注射劑75毫克
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Praluent
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.